Patent · US Active

Substance binding human IgG Fc receptor IIb (FcγRIIb)

US8853363B2 · kind B2 · utility

4Cited by
2References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 26, 2004
Grant dateOct 7, 2014
Priority date
Expiry dateSep 4, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/34
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to novel immunogens carrying conformationally discriminating epitopes (CDEs) and to immunization methods for producing antibodies that specifically recognize proteins with very closely related homologues. In particular, the invention relates to antibodies which are specific for either FcγRIIb or FcγRIIa.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.